THE USE OF ANTI-INFLAMMATORY DRUGS IN PREGNANCY AND THE RISK OF FETAL MALFORMATION
Abstract
The aim was to analyze the scientific productions about the possible effects caused by the use of anti-inflammatory drugs during pregnancy and the risk of fetal malformation. An integrative review of the literature was carried out, which is a method that aims to synthesize the results obtained in research subject or in a systematic, ordered and overarching problem through virtual Access to the databases: Medical Literature Analysis and Retrieval System Online (MEDLINE),Access through the PUBMED portal and through the Spanish Bibliographic Index of the Health Sciences (IBECS). The PICo strategy was used for the elaboration of there search question of the integrative review. Primary studies contained in articles with a qualitative and quantitative approach were selected; studies that report aspects about gestation and the association of medication use during this process; studies available in the following languages: English, Portuguese and French with no time cut.
Author Biographies
Acadêmico do Curso de Enfermagem do Centro Universitário Santo Agostinho – UNIFSA
Acadêmica do Curso de Enfermagem do Centro Universitário Santo Agostinho – UNIFSA
Professora do Curso de Enfermagem do Centro Universitário Santo Agostinho – UNIFSA
References
BLOOR, M., & PAECH, M. (2013). Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation. Anesthesiaand analgesia, 116(5), 1063–1075. Disponível em: https://doi.org/10.1213/ANE.0b013e31828a4b54
FANTIN, C.,et al. Estudo das anomalias cromossômicas ocorridas em uma maternidade nos anos de 2010 a 2014. Cogitare Enferm, 2017, 22 (1), 01-08. Disponível em: DOI: https://doi.org/10.5380/ce.v22i1.48599
GUIMARÃES, A. L. et al., Relationship of databases of live births and infant deaths for analysis of congenital malformations. RevBras Saúde MaterInfant, v. 19, n. 4: 917-24, 2019. Disponível em: https://doi.org/10.1590/1806-93042019000400010
HERNANDEZ RK, et al. National Birth Defects Prevention Study. Non steroidal antiinflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol. 2012, pp. 206(3):228.e1-228.e2288. Disponível em: DOI: https://doi.org/10.1016/j.ajog.2011.11.019
KABAMBA, A. T. et al. Prévalence de l'utilisation des anti-inflammatoires non stéroïdiens chez les femmes enceintes à Lubumbashi (RépubliqueDémocratiquedu Congo). Pan African Medical Journal. 2014; 18:132. Disponível em: DOI: https://doi.org/10.11604/pamj.2014.18.132.4091
SHARON, D. et al. Major Malformations Following Exposure to Nonsteroidal Antiinflammatory Drugs Duringt the First Trimester of Pregnancy. The JournalofRheumatology, 2012, pp. 2163-2169. Disponível em: DOI: https://doi.org/10.3899/jrheum.12045
MALAIKA, B., PHARMD, G. K., MD FRCPC FACMT, and Adrienne Einarson, RN Treating pain during pregnancy 2010. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809170/
MELNYK, B. M; OVERHOLT, E, F. Evidence- based practice in nursing and health care: a guide to best practice. 4ed. Filadélfia: LWW, 2005. Disponível em: https://cmc.marmot.org/Record/.b60769117 Acesso em 3 de Março de 2022.
MENDES, K., SILVEIRA, R., &GALVÃO, C. . Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto&Contexto - Enfermagem, 2008, pp. 758-764. Disponível em: https://doi.org/10.1590/S0104-07072008000400018
MOHER, D. et al., Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med, v. 6, n. 7, e1000097. 2009. Disponível em: DOI: https://doi.org/10.1371/jornal.pmed.1000097
SILVA, N. M. da; JUNIOR, O. M .R. Risk factors of self-medication in pregnant women: a study of non-steroidal Anti-inflammatory drugs. Research, Society and Development, 2021, v. 10, n. 15, p. e183101522993,. Disponível em: Disponível em: https://rsdjournal.org/index.php/rsd/article/view/22993 Acessado em: 23 abr.. 2022 DOI: https://doi.org/10.33448/rsd-v10i15.22993
SMYTH, E; GERALD, G. A. F; GROSSER. Anti-inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: BRUNTON, L. L; CHABNER, A. B; KNOLLMANN, B. C . Goodman & Gilman’s: The Farmacological Basis of Therapeutics, 12e. Access Medicine, 2015. Cap n° 34, p. 1-57. Disponível em: https://accessbiomedicalscience.mhmedical.com/content.aspx?bookid=1613&sectionid=102161048
Acesso em: 3 de Março de 2022.
VAN GELDER MM, ROELEVELD N, NORDENG H. Exposure to non-steroidalanti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study. PLoSOne. 2011; pp. 22174. Disponível em: DOI: https://doi.org/10.1371/journal.pone.0022174
VELEZ, E. D. R, HARTMANN K.E. Racial differences in risk of spontaneous abortions associated with periconceptional over-the- -inflammatory drug exposure. Ann Epidemiol. 2014 Feb;24(2):111-115.e1. Disponível em: Epub 2013 Nov 12. PMID: 24331921; PMCID: PMC3946756 DOI: https://doi.org/10.1016/j.annepidem.2013.11.001
License
Copyright (c) 2022 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.